Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Levobetaxolol hydrochloride
Drug ID BADD_D01266
Description A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.
Indications and Usage Used in the treatment of open-angle glaucoma and ocular hypertension [FDA Label].
Marketing Status Prescription; Discontinued
ATC Code C07AB05; S01ED02
DrugBank ID DB00195
KEGG ID D07526
MeSH ID D015784
PubChem ID 60656
TTD Drug ID D03ROX
NDC Product Code 42806-038; 42806-039; 24658-700; 60429-753; 24658-701
Synonyms Betaxolol | Betaxolol Hydrochloride | Hydrochloride, Betaxolol | Kerlone | Oxodal | Kerlon | SL-75212 | SL 75212 | SL75212 | ALO-1401-02 | ALO 1401 02 | ALO140102 | Betoptic | Betoptima | Betaxolol Alcon | Alcon, Betaxolol
Chemical Information
Molecular Formula C18H30ClNO3
CAS Registry Number 116209-55-3
SMILES CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionCytochrome P450 2D6P10635T57392Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Rhinitis22.07.03.006; 11.01.13.004--
Sinusitis22.07.03.007; 11.01.13.005--
Tachycardia02.03.02.007--Not Available
Tendonitis15.07.01.003; 12.01.07.007--Not Available
Tinnitus17.04.07.004; 04.04.01.002--
Vertigo04.04.01.003; 17.02.12.002--
Vision blurred17.17.01.010; 06.02.06.007--
Vitreous disorder06.08.03.006--Not Available
Emotional distress19.04.02.008--Not Available
Ocular discomfort06.08.03.008--Not Available
Malnutrition14.03.02.004--Not Available
Hyperlipidaemia14.08.03.001--
Cystitis noninfective20.03.02.001--
Vascular malformation24.03.03.014; 03.07.03.004--Not Available
The 2th Page    First    Pre   2    Total 2 Pages